Search Results - "Garambois, Veronique"
-
1
Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking
ISSN: 1347-9032, 1349-7006, 1349-7006Published: Tokyo John Wiley & Sons, Inc 01.07.2020Published in Cancer science (01.07.2020)“…Human epidermal growth factor receptor 4 (HER4) isoforms have oncogenic or tumor suppressor functions depending on their susceptibility to proteolytic cleavage…”
Get full text
Journal Article -
2
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice
ISSN: 2051-1426, 2051-1426Published: England BMJ Publishing Group Ltd 26.03.2025Published in Journal for immunotherapy of cancer (26.03.2025)“…BackgroundColorectal cancer (CRC) is the third most common cancer type and one of the leading causes of cancer-related death worldwide. The treatment of…”
Get full text
Journal Article -
3
STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma
ISSN: 2001-1326, 2001-1326Published: United States John Wiley & Sons, Inc 01.09.2024Published in Clinical and translational medicine (01.09.2024)“…Upper Tract Urothelial Carcinomas (UTUC) are extremely aggressive and immunosuppressed tumors of the ureter or renal pelvis with a high relapse rate (>50%)…”
Get full text
Journal Article -
4
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
ISSN: 1538-7445, 1538-7445Published: United States 01.06.2019Published in Cancer research (Chicago, Ill.) (01.06.2019)“…Although many patients with colorectal cancer initially respond to the chemotherapeutic agent oxaliplatin, acquired resistance to this treatment remains a…”
Get more information
Journal Article -
5
An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer
ISSN: 0020-7136, 1097-0215, 1097-0215Published: Hoboken, USA John Wiley & Sons, Inc 01.10.2019Published in International journal of cancer (01.10.2019)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer characterized by poor response to chemotherapy and radiotherapy due to the lack of efficient…”
Get full text
Journal Article -
6
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells
ISSN: 2045-2322, 2045-2322Published: London Nature Publishing Group UK 26.01.2021Published in Scientific reports (26.01.2021)“…In ovarian carcinoma, anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets. Here, AMH…”
Get full text
Journal Article -
7
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment
ISSN: 1532-1827, 1532-1827Published: England 10.02.2025Published in British journal of cancer (10.02.2025)“…In pancreatic ductal adenocarcinoma (PDAC), the dense stroma rich in cancer-associated fibroblasts (CAFs) and the immunosuppressive microenvironment confer…”
Get more information
Journal Article -
8
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models
ISSN: 2041-4889, 2041-4889Published: London Nature Publishing Group UK 09.06.2025Published in Cell death & disease (09.06.2025)“…The Imiqualines family is an original group of small heterocyclic compounds, diversely substituted around different scaffolds. Among these compounds, the lead…”
Get full text
Journal Article -
9
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
ISSN: 0304-3835, 1872-7980, 1872-7980Published: Ireland Elsevier B.V 28.09.2018Published in Cancer letters (28.09.2018)“…Neuregulin 1 (NRG1), a ligand for HER3 and HER4 receptors, is secreted by both pancreatic tumor cells (PC) and cancer-associated fibroblasts (CAFs), the latter…”
Get full text
Journal Article -
10
SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery
ISSN: 0960-7404, 1879-3320, 1879-3320Published: Netherlands Elsevier Ltd 01.06.2017Published in Surgical oncology (01.06.2017)“…Fluorescence-guided surgery (FGS) provides surgeons with new opportunities to improve real-time cancer nodule detection and tumor margin visualization…”
Get full text
Journal Article -
11
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells
ISSN: 2045-3701, 2045-3701Published: London BioMed Central 11.04.2023Published in Cell & bioscience (11.04.2023)“…Background Tumor resistance is a frequent cause of therapy failure and remains a major challenge for the long-term management of colorectal cancer (CRC). The…”
Get full text
Journal Article -
12
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
ISSN: 1664-3224, 1664-3224Published: Switzerland Frontiers 2023Published in Frontiers in immunology (2023)“…The ErbB family of receptor tyrosine kinases is a primary target for small molecules and antibodies for pancreatic cancer treatment. Nonetheless, the current…”
Get full text
Journal Article -
13
Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells
ISSN: 1538-7445, 1538-7445Published: United States 01.06.2008Published in Cancer research (Chicago, Ill.) (01.06.2008)“…Tight junctions have recently emerged as essential signaling regulators of proliferation and differentiation in epithelial tissues. Here, we aimed to identify…”
Get more information
Journal Article -
14
TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer
ISSN: 2050-084X, 2050-084XPublished: England eLife Science Publications, Ltd 21.10.2025Published in eLife (21.10.2025)“…In cancer cells, ATR signaling is crucial to tolerate the intrinsically high damage levels that normally block replication fork progression. Assembly of…”
Get full text
Journal Article -
15
Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells
ISSN: 1879-355X, 1879-355XPublished: United States 01.04.2020Published in International journal of radiation oncology, biology, physics (01.04.2020)“…The outcome of locally advanced cervical cancer (LACC) is dismal. Biomarkers are needed to individualize treatments and to improve patient outcomes. Here, we…”
Get more information
Journal Article -
16
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival
ISSN: 1019-6439, 1791-2423, 1791-2423Published: Greece D.A. Spandidos 01.07.2021Published in International journal of oncology (01.07.2021)“…Anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets in ovarian carcinoma. Conversely,…”
Get full text
Journal Article -
17
Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells
ISSN: 1424-8247, 1424-8247Published: Basel MDPI AG 28.06.2021Published in Pharmaceuticals (Basel, Switzerland) (28.06.2021)“…Inhibition of protein–DNA interactions represents an attractive strategy to modulate essential cellular functions. We reported the synthesis of unique…”
Get full text
Journal Article -
18
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
ISSN: 1942-0862, 1942-0870, 1942-0870Published: United States Taylor & Francis 01.01.2021Published in mAbs (01.01.2021)“…Chemoresistance, particularly to gemcitabine, is a major challenge in pancreatic cancer. The epidermal growth factor receptor (EGFR) and human epidermal growth…”
Get full text
Journal Article -
19
Shining light on drug discovery: optogenetic screening for TopBP1 biomolecular condensate inhibitors
ISSN: 2632-8674, 2632-8674Published: England Oxford University Press 01.12.2025Published in NAR cancer (01.12.2025)“…Abstract Human topoisomerase IIβ binding protein 1 (TopBP1) is a scaffold protein involved in DNA replication initiation, DNA repair, transcription regulation,…”
Get full text
Journal Article -
20
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
ISSN: 1091-6490, 1091-6490Published: United States 09.02.2010Published in Proceedings of the National Academy of Sciences - PNAS (09.02.2010)“…Symplekin is a ubiquitously expressed protein involved in cytoplasmic RNA polyadenylation and transcriptional regulation and is localized at tight junctions…”
Get more information
Journal Article